CARA - Cara Therapeutics Inc. (CARA) CEO Christopher Posner on Q4 2021 Results - Earnings Call Transcript
Cara Therapeutics, Inc. (CARA) Q4 2021 Earnings Conference Call March 01, 2022, 16:30 ET Company Participants Iris Francesconi - Interim Head, Investor Relations Christopher Posner - President, CEO & Director Thomas Reilly - CFO Joana Goncalves - Chief Medical Officer Conference Call Participants Joseph Stringer - Needham & Company Nicholas Rubino - Stifel, Nicolaus & Company Sumant Kulkarni - Canaccord Genuity Chi Zhang - Bank of America Merrill Lynch Daniel Wolle - JPMorgan Chase & Co. David Amsellem - Piper Sandler & Co. Kambiz Yazdi - Jefferies Presentation Operator Good afternoon. My name is Andrew, and I will be your conference facilitator. I would like to welcome everyone to the Cara Therapeutics Fourth Quarter 2021 Financial Results and Update Conference Call. All lines have been placed on mute to avoid any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. Please be advised that this
For further details see:
Cara Therapeutics, Inc. (CARA) CEO Christopher Posner on Q4 2021 Results - Earnings Call Transcript